Biodesix, Inc.
BDSX
$15.86
$0.563.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.76% | 15.03% | -6.11% | 18.46% | 9.72% |
| Total Depreciation and Amortization | -4.28% | -5.70% | 1.70% | 1.41% | 11.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.44% | -22.17% | -49.43% | -52.82% | -10.37% |
| Change in Net Operating Assets | 180.24% | 19.79% | 118.52% | 89.33% | 109.77% |
| Cash from Operations | 118.99% | 16.79% | 64.63% | 43.82% | 66.65% |
| Capital Expenditure | 89.75% | 79.22% | 97.35% | 68.38% | 71.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.00% | 65.45% | 38.03% | -61.54% | -164.71% |
| Cash from Investing | 88.24% | 76.57% | 95.24% | 49.82% | 70.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 61.54% | 69.23% | 58.33% | 46.15% | 0.00% |
| Issuance of Common Stock | 33,042.86% | 1,364.41% | -100.00% | -65.60% | -99.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -246.29% | -81.73% | 94.43% | -97.17% | 83.64% |
| Cash from Financing | 1,044.20% | 3,248.61% | -80.92% | -87.74% | -100.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.17% | 61.86% | -89.83% | 41.58% | -180.09% |